Stem Cell Research Ordinance (SCRO)
English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.
Art. 23 Notification after discontinuation or completion of the project or the derivation of embryonic stem cells
1 Any person who derives embryonic stem cells or carries out a research project aimed at improving derivation methods must notify the FOPH of the discontinuation or completion of stem cell derivation or the research project within 15 days. 2 Any person who carries out a research project involving embryonic stem cells must notify the FOPH and the ethics committee of the discontinuation or completion of the project within 15 days. 3 If a project is discontinued, the reasons must be indicated in the notification.
Art. 23 — Amended by No I of the O of 7 June 2024, in force since 1 Nov. 2024 (AS 2024 325).
Art. 24 Final report
1 Any person who derives embryonic stem cells or carries out a research project aimed at improving derivation methods must submit a report to the FOPH within six months of the discontinuation or completion of stem cell derivation or the research project. 2 Any person who carries out a research project involving embryonic stem cells must submit a report to the FOPH and the ethics committee within six months of the discontinuation or completion of the research project. 3 The FOPH may specify a shorter period if there is good cause for doing so; in response to a justified request from the project leader, it may in exceptional cases extend the period.
Art. 25 Content of the final report
1 The final report must document the course and results of the embryonic stem cell derivation, or of the research project aimed at improving derivation methods or involving embryonic stem cells. 2 The final report on embryonic stem cell derivation must also include the following details: a. the number of embryos used; and b. the number of embryonic stem cells derived, or the number of stem cell lines and a characterisation thereof, as specified in Article 29 paragraph 1 letter b. 3 The final report on a research project aimed at improving derivation methods must also include the following details: a. the number of embryos used; b. the number of embryonic stem cells derived, or the number of stem cell lines and a characterisation thereof, as specified in Article 29 paragraph 1 letter b, if stem cells are derived in connection with the project; c. a summary of the results obtained. 4 The final report on a research project involving embryonic stem cells must also include a summary of the
Para. 3 let. c — Amended by No I of the O of 7 June 2024, in force since 1 Nov. 2024 (AS 2024 325). Para. 4 — Amended by No I of the O of 7 June 2024, in force since 1 Nov. 2024 (AS 2024 325).
Art. 26 Storage of embryonic stem cells
Any person who stores embryonic stem cells must notify the FOPH annually, as at 1 July, of the total numbers of deposits and withdrawals, and of the number of stem cell lines stored and the characterisation thereof, as specified in Article 29 paragraph 1 letter b.